Yeni Tanı Hipertansif Hastalarda Ortalama Trombosit Hacmi ve Arteriyel Sertlik İlişkisi

Amaç: Arteriyel sertlik kardiyovasküler olayları öngörebilmesi açısından önemli bir parametredir. Çalışmamızda yeni tanı almış hipertansif hastalarda karotid-femoral nabız yayılma hızını Ortalama Trombosit Hacmi (OTH)’nin de dahil olduğu kardiyovasküler risk parametreler ile ilişkisini belirlemeyi hedefledik.. Gereç ve Yöntem: Çalışmaya 105 yeni tanı almış hipertansif hasta (ortalama yaş 44±8 yıl, 38 erkek) dahil edildi. Ambulatuar kan basıncı kayıtları, kan biyokimya ölçümleri ve kardiyovasküler belirteçleri analiz edildi ve kaydedildi. Her hastada arteriyel sertlik, Complior® cihazı ile nabız dalga yayılma tekniği kullanılarak tesbit edildi. Bulgular: Yaş (r=0.21, p=0.04), bel çevresi (r=0.16, p=0.04), Ortalama trombosit hacmi (r=0.182, p

Mean Platelet Volume and Arterial Stiffness Relation in Newly Diagnosed Hypertensive Patients

Mean Platelet Volume and Arterial Stiffness Relation in Newly Diagnosed Hypertensive Patients Objective: Arterial stifness is a highly prevalent predisposing factor in the development of cardiovascular disease. The objective of the present study is to determine the effect of mean platelet volum (MPV) on arterial stiffness (carotid-femoral pulse wave velocity) in newly diagnosed hypertensive patients. Material and Method: We enrolled 105 newly diagnosed hypertensive patients (mean age 44±8 years, 38 male) who admitted to our nephrology center. Arterial stiffness was measured by carotid femoral pulse wave velocity, using the automatic device Complior Colson® recording unit. We have recorded all laboratuary parameters and demographic features. Results: Age, systolic blood pressure, diastolic blood pressure, MPV, uric acid, total cholesterol, homocystein was positively correlated with carotid femoral pulse wave velocity. In logistic regression model, LDL-cholesterol, homocystein, MPV and age were predictor of carotid femoral pulse wave velocity. Conclusion: MPV is a readily practical and reproducible parameter that should be available in all routine blood counts. Increased MPV has been found to be a predictor of arterial stiffness in newly diagnosed hypertensive patients.

___

  • Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein: An emerging role in cardiovascular risk assessment. Crit Rev Clin Lab Sci 2002; 39: 459-97.
  • Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308-15.
  • Tsiara S, Elisaf M, Jagroop IA, et al. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9: 177-90.
  • Nadar SK, Blann AD, Kamath S, et al. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004; 44: 415- 22.
  • Ohnishi H, Saitoh S, Takagi S, et al. Pulse wave velocity as an indicator of atherosclerosis in impaired fastin glucose: the Tanno and Sobetsu study. Diabetes Care 2003; 26: 437-40.
  • Domanski MJ, Mitchell GF, Norman JE, et al. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 1999; 33: 951-8.
  • Yambe M, Tomiyama H, Hirayama Y, et al. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 2004; 27: 625-31.
  • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27: 2588–605.
  • Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? J Nephrol 2007; 20: 45- 50.
  • Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 2003; 34: 1203-6.
  • Tsiara S, Elisaf M, Jagroop IA, et al. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9: 177-90.
  • Broadley AJ, Gapper P, Schmitt M, et al. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14: 3–7.
  • Park Y, Schoene N, Harris W. Mean platelet volume as an indicator of platelet activation: Methodological issues. Platelets 2002; 13: 301-6.
  • Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157-61.
  • Hekimsoy Z, Payzin B, Ornek T, et al. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complications 2004; 18: 173-6.
  • Brown AS, Hong Y, de Belder A, et al. Megakaryocyte ploidy and platelet changes in human diabetes and atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17: 802-7.
  • Morris M, Davey FR. Basic examination of blood. In: Henry JB, editor. Clinical diagnosis and management by laboratory thmethods, 20 Edition. Philadelphia: W.B. Saunders Company; 2001. Tsiara S, Elisaf M, Jagroop IA, et al. Platelets as predictor of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9: 177-90. Pannier B, Guérin AP, Marchais SJ, et al. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 2005; 45: 592- 6. Barenbrock M, Kosch M, Jöster E, et al. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 2002; 20: 79- 84. van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32: 454-60. Willum-Hansen T, Staessen JA, Torp-Pedersen C, et al. Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 2006; 113: 664-70.
  • Asmar R. Arterial stiffness and pulse wave velocity: clinical application. Paris: Elsevier; 1999; 57-6. Amar J, Ruidavets JB, Chamontin B, et al. Arterial stiffness and cardiovascular risk factors in a population-based study. J Hypertens 2001; 19: 381-7.
  • Tsiara S, Elisaf M, Jagroop IA, et al. Platelets as predictors of vascular risk: Is there a practical index of platelet activity? Clin Appl Thromb Hemost 2003; 9: 177-90.
  • Broadley AJ, Gapper P, Schmitt M, et al. Supine rest reduces platelet activation and aggregation. Platelets 2003; 14: 3–7. Celik T, Yuksel C, Iyisoy A, et al. Effects of nebivolol on platelet activation in hypertensive patients: A comparative study with metoprolol. Int J Cardiol 2007; 116: 206-11.
  • Blann AD, Nadar S, Lip GYH. Pharmacological modulation of platelet function in hypertension. Hypertension 2003; 42: 1- 7. Nadar SK, Blann AD, Kamath S, et al. Platelet indexes in relation to target organ damage in high risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol 2004; 44: 415- 22.